Longwood Fund
Finance · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
800 Boylston St Ste 1555, Boston, Massac...Phone Number
(617) 351-2590Website
www.longwoodfund.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
2
2
2
2
About Longwood Fund
Longwood Fund is a venture capital firm that creates and invests in science-based companies focused on developing innovative solutions for significant medical challenges. The firm partners with world-class scientific co-founders to identify groundbreaking discoveries and actively collaborates in building companies, often taking leadership roles. With a strong track record, Longwood has co-founded over 25 companies and brought more than 20 therapies and products to market, significantly impacting patient care. The firm is deeply embedded in the Boston Biotech ecosystem, fostering partnerships and creating thousands of jobs in the area.Explore more
Longwood Fund Org Chart
Get the full picture
Sign in to uncover key details.
KL
Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Longwood Fund your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Longwood Fund has new funding data
Congratulate Masked Content for being promoted to Masked Content at Longwood Fund
Click to see if Longwood Fund had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Longwood Fund recently announced quarterly report
Longwood Fund, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Longwood Fund is spiking on competitors!
Product Launch: Get notified when Longwood Fund launches new products
Website visits: Recent activity has been detected on your website
Check if Longwood Fund has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Longwood Fund as Masked Content
Find 2 more new buyers
Compare Similar Companies to Longwood Fund
Compare insights from companies similar to Longwood Fund, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Longwood Fund is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Longwood Fund is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Longwood Fund.
Longwood Fund Tech Stack
A closer look at the technologies used by Longwood Fund
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Longwood Fund News & Media
Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing ... - Stock Titan
Newleos secures oversubscribed Series A funding to advance breakthrough neuropsychiatric treatments, with multiple clinical-stage assets from Roche targeting anxiety disorders.Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsychiatric Disorders through the Advancement of Novel Medicines
BOSTON--(BUSINESS WIRE)-- #BiotechStartup--Newleos Therapeutics, Inc., a clinical stage neuroscience company co-founded by Longwood Fund and seasoned leaders in CNS drug development, today announced the closing of an oversubscribed $93.5 million Series A financing. The financing was led by Goldman Sachs Alternatives with participation from Novo Holdings A/S, Longwood Fund, DCVC Bio, and Arkin Bio Capital. Newleos’ clinical-stage pipeline was in-licensed from Roche and includes multiple oral smalTome Biosciences Raises Over $213M in Series A and Series B
Tome Biosciences, Inc., a Watertown, MA-based programmable genomic integration company, raised $213m in Series A and B funding. Backers included Andreessen Horowitz (a16z) Bio + Health, ARCH Venture Partners, GV, Longwood Fund, Polaris Partners, Bruker Corporation, FUJIFILM Corporation, Alexandria Venture Investments and others. The company intends to use the funds to develop integrative gene therapies […] The post Tome Biosciences Raises Over $213M in Series A and Series B appeared first on FinLongwood Healthcare Leaders San Francisco CEO to Convene Life Science Thought Leaders Prior to JPM
Longwood Fund, an early-stage life science venture firm, will convene top biopharmaceutical leaders for two days of off-the-record discussions, J ...
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Longwood Fund
Sign Up For FreeTo access detailed company insights
Longwood Fund is a venture capital firm that creates and invests in science-based companies focused on developing innovative solutions for significant medical challenges. The firm partners with world-class scientific co-founders to identify groundbreaking discoveries and actively collaborates in building companies, often taking leadership roles. Wi... Read More
